跳到正文
American Aging Association (@Americanaging)· americanaging·· 13 天前评分18

雷帕霉素低剂量试药:APOE4携带者脑血流升逾15%

Rapamycin is the most talked-about drug in aging biology. What does a first look in healthy middle-aged people actually show?

导读

密苏里大学一项单臂试点试验给45至65岁认知正常成人每日1 mg雷帕霉素、持续4周,23名完成者中9名APOE4携带者多个脑区脑血流(主要终点)升高逾15%,非携带者无显著变化。代谢与炎症指标改善、不良反应极少,但该试验无安慰剂组、样本极小,脑血流仅为生物标志物,不能证明记忆改善或预防阿尔茨海默病,长期或重复给药效果未知。

来源:American Aging Association (@Americanaging) · x.com